New Enterprise Associates 15, L.P. Senti Biosciences, Inc. (SNTI) insider trading activity

New Enterprise Associates 15, L.P. is of Senti Biosciences, Inc.. Currently has a direct ownership of 3.78 Million shares of SNTI, which is worth approximately $13 Million. The most recent transaction as insider was on Mar 10, 2025, when has been sold 3,333,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.78M

n/a 3M change

n/a 12M change

Total Value Held $13 Million

New Enterprise Associates 15, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 10 2025	BUY Conversion of derivative security	-	3,333,000 Added 46.89%	3,775,615 Common Stock

Also insider at

EAR

Eargo, Inc. Healthcare

> 10% Shareholder

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

Desktop Metal, Inc. Technology

> 10% Shareholder

BHG

Bright Health Group Inc. Healthcare

HOOD

Robinhood Markets, Inc. Technology

Director

ACLX

Arcellx, Inc. Healthcare

> 10% Shareholder

IONQ

IonQ, Inc. Technology

> 10% Shareholder

AVEO

AVEO PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

BGRY

Berkshire Grey, Inc. Industrials

> 10% Shareholder

NEA